Invivyd · 2 weeks ago
Senior Manager/Associate Director, Clinical Operations
Invivyd is a company dedicated to delivering protection from serious viral infectious diseases, including COVID-19. The Senior Manager/Associate Director of Clinical Operations will oversee clinical trial management activities, ensuring successful execution of studies from protocol concept through to the clinical study report while managing external partnerships and mentoring staff.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Oversee study management activities for local and global monoclonal antibody clinical research studies (Phase 1-4)
Responsible for clinical trial management activities on specified study in addition to local and global CRO oversight
Lead selection and management/oversight of external vendors; develop standard vendor specifications; review vendor reports, budgets and forecasts, and metrics
Review and negotiate contracts
Forecast costs for clinical studies
Review and approve invoices against approved budget/contract
Monitor subject accrual and study progress via standard reports
Oversee clinical monitoring from site qualification to site closure visits and ensure integrity of clinical data with respect to accuracy, accountability, and documentation through review of monitoring reports and completed case report forms
Update program team and Clinical Operations management on timelines and progress toward milestones
Apply Invivyd and industry standards across research program(s)
Provide guidance to Clinical Operations Leads in oversight of vendors and investigators to ensure compliance with the study protocol and overall clinical objectives
Collaborate with study leads to establish performance and quality metrics for the study and report metrics and that drive quality and efficiency
Work with Clinical Operations/Development management to support timely and in-budget completion of department goals by ensuring compliance and continuity with relevant SOPs and organizational work instructions
Support departmental initiatives aimed at innovation, process improvement, and efficiency
Develop or contribute to key vendor oversight plans and processes
Assist with the development of standard operating procedures (SOPs), work instructions (WIs), and standardized forms to define Clinical Department processes
Collaborate with Clinical, Regulatory, Safety, Quality, and other functional team members to ensure compliance of department/study activities with FDA regulations, guidelines, and principles of ICH GCP and Invivyd SOPs
Ensure GCP compliance by providing guidance and support to Clinical study leads and Clinical Study Teams
Support activities associated with QA audits: as needed, assist the clinical trial teams in responding to audit findings, ensuring appropriate root cause is performed and CAPAs are created; ensure all items are documented appropriately
Manage direct reports, as applicable
Limited travel (<20%) for site and vendor oversight
Qualification
Required
Minimum education and experience: bachelor's degree with 5-7 years relevant experience
Local and global study management at Sponsor company
Strong oral and written communication skills
Experience with development and maintenance of study timelines and budgets
Highly adaptable, proactive, deadline and detail-oriented
High level of professional expertise through recent industry training and familiarity with good clinical practice and risk-based quality management best practices
The candidate will work independently in a fast-paced and dynamic environment
Ability to accommodate hybrid schedule with a mix of both onsite (New Haven, CT once a month) and remote working
Ability to travel up to 20% for site and vendor oversight
Company
Invivyd
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Funding
Current Stage
Public CompanyTotal Funding
$678.5MKey Investors
Silicon Valley BankRA Capital ManagementGoogle Ventures
2025-11-17Post Ipo Equity· $125M
2025-08-20Post Ipo Equity· $57.5M
2025-04-21Post Ipo Debt· $30M
Recent News
2025-12-24
2025-12-24
Company data provided by crunchbase